Smith & Nephew receives FDA 510(k) clearance of shoulder arthroplasty system
Click Here to Manage Email Alerts
Key takeaways:
- Smith & Nephew received FDA 510(k) clearance of its AETOS shoulder system.
- The system is indicated for patients undergoing anatomic and reverse total shoulder arthroplasty.
Smith & Nephew has announced FDA 510(k) clearance of its AETOS shoulder system for patients undergoing anatomic and reverse total shoulder arthroplasty, according to a company press release.
The AETOS system also features the AETOS meta stem, a convertible humeral stem designed to improve stability and preserve bone, according to the release.
“Receiving FDA clearance for the AETOS shoulder system is a major milestone for Smith & Nephew,” Brad Cannon, president of global orthopedics at Smith & Nephew, said in the release. “This platform is the culmination of years of research and development and represents our commitment to providing health care professionals with the best possible technology for their patients. We are confident that this platform will further evolve the standard of care for shoulder surgery and are excited to see the impact it has on patient outcomes,” Cannon said.
Read more about
Click Here to Manage Email Alerts